Met Life Investment Management, LLC Biotechnology

Met Life Investment Management, LLC

$18.1 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
VRTX Vertex Pharmaceuticals Inc	$121B	$35.1 Million 0.19% of portfolio	72,361	Q1 2025 Reduced 2.06%
ADMA Adma Biologics, Inc.	$3.35B	$22 Million 0.12% of portfolio	1,108,911	Q1 2025 Added 714.11%
HALO Halozyme Therapeutics, Inc.	$8.01B	$21.9 Million 0.12% of portfolio	343,741	Q1 2025 Added 136.63%
AXSM Axsome Therapeutics, Inc.	$4.4B	$20.9 Million 0.12% of portfolio	178,955	Q1 2025 Added 703.32%
REGN Regeneron Pharmaceuticals, Inc.	$60.1B	$17.6 Million 0.1% of portfolio	27,697	Q1 2025 Reduced 1.92%
CPRX Catalyst Pharmaceuticals, Inc.	$2.15B	$17.6 Million 0.1% of portfolio	724,091	Q1 2025 Added 963.48%
INSM Insmed Inc	$13.9B	$7.65 Million 0.04% of portfolio	100,210	Q1 2025 Reduced 3.11%
UTHR United Therapeutics Corp	$13.6B	$7.64 Million 0.04% of portfolio	24,775	Q1 2025 Reduced 1.49%
BMRN Biomarin Pharmaceutical Inc	$11B	$7.51 Million 0.04% of portfolio	106,226	Q1 2025 Reduced 1.1%
EXEL Exelixis, Inc.	$14.3B	$6.11 Million 0.03% of portfolio	165,617	Q1 2025 Reduced 3.27%
CORT Corcept Therapeutics Inc	$7.4B	$5.41 Million 0.03% of portfolio	47,363	Q1 2025 Reduced 3.03%
CYTK Cytokinetics Inc	$3.55B	$5.23 Million 0.03% of portfolio	130,022	Q1 2025 Reduced 2.75%
JAZZ Jazz Pharmaceuticals PLC	$7.29B	$4.16 Million 0.02% of portfolio	33,545	Q1 2025 Reduced 1.56%
SRPT Sarepta Therapeutics, Inc.	$1.19B	$3.63 Million 0.02% of portfolio	56,954	Q1 2025 Reduced 1.38%
RVMD Revolution Medicines, Inc.	$3.36B	$3.5 Million 0.02% of portfolio	98,886	Q1 2025 Reduced 1.44%
MDGL Madrigal Pharmaceuticals, Inc.	$5.36B	$3.46 Million 0.02% of portfolio	10,453	Q1 2025 Reduced 3.37%
BPMC Blueprint Medicines Corp	$7.73B	$3.32 Million 0.02% of portfolio	37,514	Q1 2025 Reduced 1.54%
TGTX Tg Therapeutics, Inc.	$5.43B	$3.2 Million 0.02% of portfolio	81,232	Q1 2025 Reduced 3.71%
BBIO Bridge Bio Pharma, Inc.	$6.79B	$2.83 Million 0.02% of portfolio	81,935	Q1 2025 Reduced 4.69%
PCVX Vaxcyte, Inc.	$2.12B	$2.73 Million 0.02% of portfolio	72,188	Q1 2025 Reduced 3.11%
KRYS Krystal Biotech, Inc.	$3.9B	$2.62 Million 0.01% of portfolio	14,524	Q1 2025 Reduced 3.15%
INCY Incyte Corp	$15.3B	$2.55 Million 0.01% of portfolio	42,094	Q1 2025 Reduced 1.46%
MRNA Moderna, Inc.	$12.8B	$2.49 Million 0.01% of portfolio	87,673	Q1 2025 Reduced 1.88%
TECH Bio Techne Corp	$2.08B	$2.41 Million 0.01% of portfolio	41,038	Q1 2025 Reduced 2.26%
ROIV Roivant Sciences Ltd.	$8.1B	$2.36 Million 0.01% of portfolio	233,742	Q1 2025 Reduced 3.43%
PTCT Ptc Therapeutics, Inc.	$3.32B	$2.26 Million 0.01% of portfolio	44,354	Q1 2025 Reduced 4.8%
ALNY Alnylam Pharmaceuticals, Inc.	$40B	$1.97 Million 0.01% of portfolio	7,295	Q1 2025 Reduced 0.12%
RNA Avidity Biosciences, Inc.	$1.75B	$1.94 Million 0.01% of portfolio	65,873	Q1 2025 Reduced 1.38%
SWTX Spring Works Therapeutics, Inc.	$2.93B	$1.8 Million 0.01% of portfolio	40,764	Q1 2025 Reduced 3.15%
CRNX Crinetics Pharmaceuticals, Inc.	$1.64B	$1.79 Million 0.01% of portfolio	53,414	Q1 2025 Added 0.74%
AKRO Akero Therapeutics, Inc.	$2.41B	$1.76 Million 0.01% of portfolio	43,498	Q1 2025 Added 4.65%
RYTM Rhythm Pharmaceuticals, Inc.	$4.89B	$1.72 Million 0.01% of portfolio	32,414	Q1 2025 Reduced 3.24%
PTGX Protagonist Therapeutics, Inc	$2.7B	$1.68 Million 0.01% of portfolio	34,790	Q1 2025 Reduced 2.82%
ACLX Arcellx, Inc.	$2.98B	$1.68 Million 0.01% of portfolio	25,610	Q1 2025 Reduced 1.72%
SRRK Scholar Rock Holding Corp	$2.06B	$1.48 Million 0.01% of portfolio	46,049	Q1 2025 Reduced 1.32%
NUVL Nuvalent, Inc.	$3.47B	$1.47 Million 0.01% of portfolio	20,763	Q1 2025 Reduced 1.56%
FOLD Amicus Therapeutics, Inc.	$1.74B	$1.42 Million 0.01% of portfolio	174,057	Q1 2025 Reduced 3.06%
VCYT Veracyte, Inc.	$1.68B	$1.38 Million 0.01% of portfolio	46,392	Q1 2025 Reduced 1.18%
VCEL Vericel Corp	$1.79B	$1.3 Million 0.01% of portfolio	29,187	Q1 2025 Reduced 1.43%
ACAD Acadia Pharmaceuticals Inc	$3.65B	$1.19 Million 0.01% of portfolio	71,835	Q1 2025 Reduced 1.66%
TARS Tarsus Pharmaceuticals, Inc.	$1.13B	$1.15 Million 0.01% of portfolio	22,305	Q1 2025 Reduced 1.64%
LGND Ligand Pharmaceuticals Inc	$2.24B	$1.08 Million 0.01% of portfolio	10,292	Q1 2025 Reduced 1.81%
BEAM Beam Therapeutics Inc.	$1.52B	$1.07 Million 0.01% of portfolio	55,008	Q1 2025 Added 17.29%
MIRM Mirum Pharmaceuticals, Inc.	$1.92B	$1.07 Million 0.01% of portfolio	23,724	Q1 2025 Reduced 1.5%
SMMT Summit Therapeutics Inc.	$5.55B	$1.05 Million 0.01% of portfolio	54,691	Q1 2025 Reduced 1.29%
DNLI Denali Therapeutics Inc.	$1.86B	$1.02 Million 0.01% of portfolio	74,765	Q1 2025 Reduced 1.69%
ARQT Arcutis Biotherapeutics, Inc.	$876M	$1.01 Million 0.01% of portfolio	64,485	Q1 2025 Reduced 1.51%
AGIO Agios Pharmaceuticals, Inc.	$2.17B	$997,000 0.01% of portfolio	34,032	Q1 2025 Reduced 1.58%
EWTX Edgewise Therapeutics, Inc.	$855M	$965,000 0.01% of portfolio	43,883	Q1 2025 Reduced 1.63%
IMVT Immunovant, Inc.	$3.55B	$965,000 0.01% of portfolio	35,095	Q1 2025 Reduced 1.55%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.